Comprehensive Analysis of the Next-Generation Sequencing Data Analysis Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the next-generation sequencing data analysis market size evolved in recent years?
The next-generation sequencing data analysis market has experienced exponential growth, projected to rise from $1.21 billion in 2024 to $1.48 billion in 2025, with a CAGR of 22.0%. Driving factors include expanded use in pathogen detection, veterinary diagnostics, rare genetic disorder analysis, microbiome research, and pharmacogenomics.
What are the predictions for the next-generation sequencing data analysis market size in the coming years?
The next-generation sequencing (NGS) data analysis market is set for exponential growth, reaching $3.24 billion by 2029 with a CAGR of 21.7%. Growth will be driven by increasing genomics integration in healthcare, educational initiatives for professionals, public health surveillance, cost reductions in sequencing, and a rising interest in epigenetics. Key trends include advances in single-cell sequencing, automation in NGS data analysis, improved visualization tools, blockchain adoption, and hybrid sequencing techniques.
Get your next-generation sequencing data analysis market report here!
What key factors are fueling the growth of the next-generation sequencing data analysis market?
The growing prevalence of cancer is anticipated to drive the expansion of the next-generation sequencing data analysis market. Cancer is a group of diseases characterized by abnormal cell growth, which can result in serious health complications if not treated. Risk factors like smoking, excessive alcohol consumption, and poor diets are major contributors to cancer. Next-generation sequencing data analysis helps identify genetic mutations, enabling personalized treatments and more effective strategies tailored to the genetic makeup of an individual’s cancer. For example, by 2050, over 35 million new cancer cases are projected, a 77% increase from 2022. This growing cancer prevalence is boosting the market for next-generation sequencing data analysis.
How is the global next-generation sequencing data analysis market divided into key segments?
The next-generation sequencing data analysismarket covered in this report is segmented –
1) By Product: Services, Next-Generation Sequencing (NGS) Commercial Software
2) By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing
3) By Mode: In-House, Outsourced
4) By Workflow: Primary, Secondary, Tertiary
5) By End-User: Academic Research, Clinical Research, Hospitals And Clinics, Pharma And Biotech Entities, Other End-Users
Subsegments:
1) By Services: Data Analysis Services, Bioinformatics Services, Consulting Services, Sample Preparation Services, Training and Support Services
2) By Next-Generation Sequencing (NGS) Commercial Software: Data Management Software, Alignment Software, Variant Calling Software, Visualization Software, Pipeline Management Software, Specialized Analysis Software
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19614&type=smp
Who are the key firms paving the way for growth in the next-generation sequencing data analysis market?
Major companies operating in the next-generation sequencing data analysis market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., MedGenome Inc., Element Biosciences Inc., Seven Bridges Genomics Inc., Synthego Corp., Eurofins Genomics India Pvt. Ltd., Fabric Genomics Inc., Strand Life Sciences Pvt. Ltd., Admera Health LLC, Congenica Ltd., DNASTAR Inc., Golden Helix Inc., Geneious, SciGenom Labs Pvt. Ltd., Partek Incorporated, PathoQuest SAS, BioDatomics Inc., BGI Genomics Co. Ltd
Which trends are expected to transform the next-generation sequencing data analysis market?
Leading businesses involved in the next-generation sequencing data analysis sector are concentrating on creating sophisticated secondary analysis bioinformatics software. This enhanced software can facilitate the quick and accurate detection of genetic variations for research and clinical uses. Secondary analysis bioinformatics software processes raw sequencing information from next-generation sequencing (NGS) and transforms it into formats that are easy to interpret, such as variant call files (VCF), which provide information on genetic variations. This specialized software simplifies the assessment of NGS data for research and clinical objectives. For example, in January 2024, QIAGEN Digital Insights, QIAGEN’s bioinformatics division in the USA, introduced its QIAGEN CLC Genomics Workbench Premium using LightSpeed technology. This novel software is designed to expedite next-generation sequencing (NGS) in the field of somatic cancer analysis and rapidly process whole genome sequencing (WGS) samples. It has the capacity to process 34x human genomes in 25 minutes and 50x exomes in 90 seconds with the help of LightSpeed technology, which effectively transforms raw FASTQ data into easily interpretable formats. This software is a budget-friendly option for high-capacity laboratories, with expenses as little as $1 for genomes and a few cents for exomes when using cloud infrastructure. The software can operate on standard hardware or cloud-based platforms, providing versatility and a high level of precision, making it an excellent choice for clinical application and reducing its environmental impact.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19614
What regions are contributing significantly to the growth of the next-generation sequencing data analysis market?
North America was the largest region in the next-generation sequencing data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Next-Generation Antibody Therapeutics Global Market Report 2024
Next-Generation Network Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/next-generation-network-global-market-report
Next-Generation Gynecological Cancer Diagnostics Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
